Mucosal barriers and innate immune responses protect us from invasive infection by many non-pathogenic bacteria. However, certain bacterial pathogens have evolved strategies to cross mucosal barriers and consequently establish severe, life-threatening systemic infections. Our studies have revealed a weak link in the innate immune response that we hypothesize is exploited by these pathogens during their establishment of systemic disease. These recent studies implicate natural killer (NK) cells as a major source of interleukin (IL)- 10 production during systemic infection by the pathogen Listeria monocytogenes. IL-10 is a cytokine that many pathogenic bacteria exploit during the establishment of severe infection. It was not previously appreciated that NK cells are the major source of ?pro-bacterial? IL-10 production. We further found that a secreted L. monocytogenes bacterial virulence protein, p60, promotes NK cell IL-10 production by stimulating dendritic cells (DC) to produce IL-18 and other essential factors. Our studies here address mechanisms by which these factors coordinate NK cell activation to produce IL-10. We also investigate the impact of NK cell IL-10 on the ability of these pathogens to cross different mucosal barriers to establish systemic disease. The mechanistic information obtained through these studies may reveal strategies to promote or inhibit NK cell IL-10 production to improve human health.

Public Health Relevance

Our studies focus on dissecting the mechanisms by which bacterial infections and specific bacterial virulence proteins can stimulate ?pro-bacterial? host innate immune responses. Results from these studies may reveal strategies to prevent or manipulate these responses in therapy of infections and inflammatory diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI131662-04
Application #
9915847
Study Section
Immunity and Host Defense (IHD)
Program Officer
Lapham, Cheryl K
Project Start
2017-05-10
Project End
2022-04-30
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
4
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Soderborg, Taylor K; Clark, Sarah E; Mulligan, Christopher E et al. (2018) The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD. Nat Commun 9:4462
Clark, Sarah E; Schmidt, Rebecca L; McDermott, Daniel S et al. (2018) A Batf3/Nlrp3/IL-18 Axis Promotes Natural Killer Cell IL-10 Production during Listeria monocytogenes Infection. Cell Rep 23:2582-2594
Ortiz, Amber L; Lenz, Laurel L (2017) A Listeria-derived polypeptide promotes in vivo activation of NK cells for antitumor therapy. Immunohorizons 1:53-62